BPA Call 19GE5021A0003-19GE5022F7012
Award Date 9/1/22
Potential Completion Date 8/31/23
Potential Value $26K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
- This is a $138,356.92 firm fixed price purchase order awarded by the Department of Health and Human Services to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The contract is for a "NGS PLATFORM SEQUENCING SYSTEM" to support the Centers for Disease Control and Prevention's (CDC) infectious disease monitoring and research programs in Thailand. Bio-Active Company LIMITED has a history of providing genetic sequencing systems, reagents, and testing...
- This federal contract award is for services related to the Illumina MiSeq genetic sequencing system. The $26,537.08 firm fixed price contract was issued as a call under a Blanket Purchase Agreement (BPA) held by Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The work is being performed for the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency. No set-aside designation was used for this award. Bio-Active Company...
- This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
- This is a firm fixed price contract awarded by the Office of Intergovernmental and External Affairs, a civilian agency, to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq genetic sequencing system. The contract has a ceiling value of $27,212.02 and a period of performance through August 31, 2025. This is a call order issued against a previously established Blanket Purchase Agreement held by Bio-Active Company LIMITED to provide...
- This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
- The Department of State Bureau of European and Eurasian Affairs awarded a $110,238 firm fixed price purchase order to Bio-Active Company LIMITED of Thailand to acquire reagent kits and DNA sets on behalf of the Centers for Disease Control and Prevention in Thailand. The contract period of performance spans from August 31, 2023 through November 2, 2023 and will deliver requested biological samples and testing materials to support CDC programs in the region. No subcontractors or set aside...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Bio-Active Company LIMITED, a for-profit limited liability company located in Thailand. The $112,739.29 contract is for the purchase of an Illumina MiSeq genetic sequencing system, including reagents and associated components. This award is not associated with a larger contract vehicle, and no small business set-aside provisions were used. Bio-Active Company LIMITED...
- This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
- This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...